Skip to main content
Erschienen in: Clinical Rheumatology 2/2008

01.02.2008 | Brief Report

Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis

verfasst von: Valeria Riccieri, Antonio Spadaro, Leos Fuksa, Omidreza Firuzi, Luciano Saso, Guido Valesini

Erschienen in: Clinical Rheumatology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Oxidative stress is suggested to be involved in the pathogenesis of systemic sclerosis (SSc). The aim of the present study was to clarify such a hypothesis by determination of four different plasmatic parameters of oxidative stress, and to define its role in the microvascular damage, assessed by nailfold capillaroscopy (NC). Plasma samples of 18 patients with SSc were analyzed. The biomarkers measured were: total antioxidant capacity, hydroperoxides (ROOHs), and sulfhydryl (SH) and carbonyl (CO) groups. Each patient had a detailed clinical assessment and underwent an NC. The results showed significantly increased ROOHs in SSc patients compared to control group (5.02 ± 0.24 vs 3.28 ± 0.19 μmol/l; p < 0.05). Plasmatic levels of SH groups were significantly lower in SSc (0.466 ± 0.08 mmol/l) compared to control group (0.542 ± 0.04 mmol/l; p < 0.002). Plasma levels of ROOHs correlated with the capillaroscopy semiquantitative rating scale score (p < 0.05) and with the rating system for avascular areas (p < 0.03). The levels of CO groups inversely correlated with modified Rodnan’s skin score (p < 0.039) and were lower in patients with pulmonary fibrosis (p < 0.045), while the levels of SH groups were lower in those presenting gastrointestinal involvement (p < 0.029). The obtained data indicate augmented free radical-mediated injury in SSc and also show correlations among oxidative abnormalities, some clinical findings, and signs of a more severe microvascular involvement. These results give more evidence to the connection between oxidative impairment and SSc.
Literatur
1.
Zurück zum Zitat Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis. Autoimmunity 31:195–214PubMedCrossRef Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis. Autoimmunity 31:195–214PubMedCrossRef
2.
Zurück zum Zitat Murrell DF (1993) A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78–85PubMedCrossRef Murrell DF (1993) A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78–85PubMedCrossRef
3.
Zurück zum Zitat Simonini G, Matucci Cerinic M, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M (1999) Oxidative stress in systemic sclerosis. Mol Cell Biochem 196:85–91PubMedCrossRef Simonini G, Matucci Cerinic M, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M (1999) Oxidative stress in systemic sclerosis. Mol Cell Biochem 196:85–91PubMedCrossRef
4.
Zurück zum Zitat Herrick AL, Matucci Cerinic M (2001) The emergin problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4–8PubMed Herrick AL, Matucci Cerinic M (2001) The emergin problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4–8PubMed
5.
Zurück zum Zitat Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxid production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxid production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed
6.
Zurück zum Zitat Matucci Cerinic M, Kahaleh MB (2002) Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41:843–847CrossRef Matucci Cerinic M, Kahaleh MB (2002) Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41:843–847CrossRef
7.
Zurück zum Zitat Ahsan H, Ali A, Ali R (2003) Oxigen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398–404PubMedCrossRef Ahsan H, Ali A, Ali R (2003) Oxigen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398–404PubMedCrossRef
8.
Zurück zum Zitat Pratico D (2001) In vivo measurement of the redox state. Lipids 36(suppl):45–47CrossRef Pratico D (2001) In vivo measurement of the redox state. Lipids 36(suppl):45–47CrossRef
9.
Zurück zum Zitat Deaney CL, Feyi K, Forrest CM, Freeman A, Harman G, McDonald MS, Petrie A, Shaw SJ, Stone TW, Stoy N, Darlington LG (2001) Levels of lipid peroxidation products in a chronic inflammatory disorder. Res Commun Mol Pathol Pharmacol 110(1–2):87–95PubMed Deaney CL, Feyi K, Forrest CM, Freeman A, Harman G, McDonald MS, Petrie A, Shaw SJ, Stone TW, Stoy N, Darlington LG (2001) Levels of lipid peroxidation products in a chronic inflammatory disorder. Res Commun Mol Pathol Pharmacol 110(1–2):87–95PubMed
10.
Zurück zum Zitat Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthrits Rheum 24:1159–1165CrossRef Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthrits Rheum 24:1159–1165CrossRef
11.
Zurück zum Zitat Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155–160PubMed
12.
Zurück zum Zitat Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Arthritis Rheum 23(5):581–590CrossRef Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Arthritis Rheum 23(5):581–590CrossRef
13.
Zurück zum Zitat Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC (1986) A modified scleroderma skin scoring method. Clin Exp Rheumatol 4(4):367–369PubMed Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC (1986) A modified scleroderma skin scoring method. Clin Exp Rheumatol 4(4):367–369PubMed
14.
Zurück zum Zitat Steen VD, Powell DL, Medsger TA (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef Steen VD, Powell DL, Medsger TA (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef
15.
Zurück zum Zitat Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef
16.
Zurück zum Zitat Lee P, Leung FYK, Alderice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938PubMed Lee P, Leung FYK, Alderice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938PubMed
17.
Zurück zum Zitat Firuzi O, Giansanti L, Vento R, Seidert C, Petrucci R, Marrosu G, Agostino R, Saso L (2003) Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines. J Pharm Pharmacol 55:1021–1027PubMedCrossRef Firuzi O, Giansanti L, Vento R, Seidert C, Petrucci R, Marrosu G, Agostino R, Saso L (2003) Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines. J Pharm Pharmacol 55:1021–1027PubMedCrossRef
18.
Zurück zum Zitat Firuzi O, Mladenka P, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Parameters of oxidative stress status in healthy subjects; their correlations and their stability after sample collection. J Clin Lab Anal 20:139–148PubMedCrossRef Firuzi O, Mladenka P, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Parameters of oxidative stress status in healthy subjects; their correlations and their stability after sample collection. J Clin Lab Anal 20:139–148PubMedCrossRef
19.
Zurück zum Zitat Firuzi O, Fuksa L, Spadaro C, Bousova I, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 58:951–957PubMedCrossRef Firuzi O, Fuksa L, Spadaro C, Bousova I, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 58:951–957PubMedCrossRef
20.
Zurück zum Zitat Lau CS, O’Dowd A, Belch JJ (1992) White blood cell activation in Raynaud’s phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis 51:249–252PubMed Lau CS, O’Dowd A, Belch JJ (1992) White blood cell activation in Raynaud’s phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis 51:249–252PubMed
21.
Zurück zum Zitat Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A (2004) High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50:2190–2193PubMedCrossRef Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A (2004) High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50:2190–2193PubMedCrossRef
22.
Zurück zum Zitat Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud’s phenomenon and systemic sclerosis. J Rheumatol 21:1477–1483PubMed Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud’s phenomenon and systemic sclerosis. J Rheumatol 21:1477–1483PubMed
23.
Zurück zum Zitat Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173–1181PubMedCrossRef Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173–1181PubMedCrossRef
24.
Zurück zum Zitat Morita A, Minami H, Sakakibara N, Sato K, Tsuji T (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196–201PubMedCrossRef Morita A, Minami H, Sakakibara N, Sato K, Tsuji T (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196–201PubMedCrossRef
25.
Zurück zum Zitat Halliwell B (1995) Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 54:505–510PubMed Halliwell B (1995) Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 54:505–510PubMed
Metadaten
Titel
Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis
verfasst von
Valeria Riccieri
Antonio Spadaro
Leos Fuksa
Omidreza Firuzi
Luciano Saso
Guido Valesini
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 2/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0769-9

Weitere Artikel der Ausgabe 2/2008

Clinical Rheumatology 2/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.